Role of adenosine in tumor progression: focus on A_2B receptor as potential therapeutic target

Abstract

Adenosine receptors are a family of G-coupled receptors which mediate the anti-inflammatory and immune-suppressive effects of adenosine in a damaged tissue. A large number of evidence indicate that the accumulation of adenosine under hypoxic conditions favors tumor progression, helping cancer cells to evade immune responses. Tumor cells and/or lymphoid and myeloid cells can express the adenosine-generating enzyme CD73 and/or A_2A receptor, which in turn strongly suppresses an effective T-cell-mediated response, while promotes the activity of suppressive cells such as Treg and myeloid-derived suppressor cells. CD73 inhibitors and A_2A antagonists, either as single agents, or in combination with immune-checkpoints inhibitors such as anti PD-1 monoclonal antibodies, are currently in Phase I clinical trial in cancer patients. Recent studies show that A_2B receptor plays an important role in mediating the pro-tumor effects of adenosine, since its selective blockade can inhibit tumor growth in some murine tumor models. Targeting A_2B receptor reduces immunosuppression induced by myeloid cells and inhibits the stromal cells activity within the tumor microenvironment, limiting tumor angiogenesis and metastatic processes. Here, the authors review the current data on involvement of A_2B receptor in regulating tumor progression and discuss the development of A_2B receptor inhibitors as potential therapeutic agents in cancer treatment.

Keywords

CD73/A₂ adenosine receptors axis / A_2B adenosine receptor / tumor immunity / tumor metastasis / tumor angiogenesis / cancer treatment

References

[1] Pietras K.Hallmarks of cancer: interactions with the tumor stroma..Exp Cell Res2010;316:1324-31

[2] Klemm F.Microenvironmental regulation of therapeutic response in cancer..Trends Cell Biol2015;25:198-213 PMCID:PMC5424264

[3] DeVita VT.A history of cancer chemotherapy..Cancer Res2008;68:8643-53

[4] Baskar R,Wenlong N,Yeoh KW.Biological response of cancer cells to radiation treatment..Front Mol Biosci2014;17:1-24

[5] Druker BJ.Karnofsky Award lecture. Imatinib as a paradigm of targeted therapies..J Clin Oncol2003;21:239-45s

[6] Couzin-Frankel J.Cancer immunotherapy..Science2013;342:1432-3

[7] Disis ML.Immune regulation of cancer..J Clin Oncol2010;28:4531-8 PMCID:PMC3041789

[8] Pardoll DM.The blockade of immune checkpoints in cancer immunotherapy..Nat Rev Cancer2012;12:252-64 PMCID:PMC4856023

[9] Hodi FS,McDermott DF,Sosman JA,Gonzalez R,Schadendorf D,Akerley W,Lutzky J,Vaubel JM,Hogg D,Lebbé C,Quirt I,Wolchok JD,Tian J,Nichol GM,Urba WJ.Improved survival with ipilimumab in patients with metastatic melanoma..N Engl J Med2010;363:711-23 PMCID:PMC3549297

[10] Ohta A,Prasad SJ,Lukashev D,Huang X,Liu K,Chen JF,Apasov S,Sitkovsky M.A2A adenosine receptor protects tumors from antitumor T cells..Proc Natl Acad Sci U S A2006;103:13132-7 PMCID:PMC1559765

[11] Sitkovsky MV,Abbott R,Lukashev D.Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists..Cancer Immunol Res2014;2:598-605 PMCID:PMC4331061

[12] Vaupel P.Hypoxia-driven adenosine accumulation: a crucial microenvironmental factor promoting tumor progression..Adv Exp Med Biol2016;876:177-83

[13] Leone RD,Powell JD.A2aR antagonists: next generation checkpoint blockade for cancer immunotherapy..Comput Struct Biotechnol J2015;13:265-72 PMCID:PMC4415113

[14] Allard B,Robson SC.The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets..Immunol Rev2017;276:121-44 PMCID:PMC5338647

[15] Antonioli L,Vizi ES.CD39 and CD73 in immunity and inflammation..Trends Mol Med2013;19:355-67 PMCID:PMC3674206

[16] Yegutkin GG.Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities..Crit Rev Biochem Mol Biol2014;49:473-97

[17] Fredholm BB,Jacobson KA,Linden J.International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors..Pharmacol Rev2001;53:527-52

[18] Borea PA,Merighi S.Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?.Trends Pharmacol Sci2016;37:419-34

[19] Sitaraman SV,Wang L,Gewirtz AT,Madara JL.Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6..J Clin Invest2001;107:861-9 PMCID:PMC199578

[20] Lynge J,Nordsborg N,Hellsten Y.Adenosine A 2B receptors modulate cAMP levels and induce CREB but not ERK1/2 and p38 phosphorylation in rat skeletal muscle cells..Biochem Biophys Res Commun2003;307:180-7

[21] Fang Y.Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1)..J Pharmacol Exp Ther2007;322:1189-200

[22] Darashchonak N,Kleppa MJ,von Versen-Höynck F.Activation of adenosine A2B receptor impairs properties of trophoblast cells and involves mitogen-activated protein (MAP) kinase signaling..Placenta2014;35:763-71

[23] Gao Z,Weber MJ.A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways..J Biol Chem1999;274:5972-80

[24] Panjehpour M,Klotz KN.Human breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal..Br J Pharmacol2005;145:211-8 PMCID:PMC1576131

[25] Schulte G.Signalling from adenosine receptors to mitogen-activated protein kinases..Cell Signal2003;15:813-27

[26] Fredholm BB.Adenosine, an endogenous distress signal, modulates tissue damage and repair..Cell Death Differ2007;14:1315-23

[27] Antonioli L,Pacher P.Immunity, inflammation and cancer: a leading role for adenosine..Nat Rev Cancer2013;13:842-57

[28] Ohta A.Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage..Nature2001;414:916-20

[29] Haskó G,Cronstein B.Adenosine receptors: therapeutic aspects for inflammatory and immune diseases..Nat Rev Drug Discov2008;7:759-70 PMCID:PMC2568887

[30] Morello S,Pinto A.Adenosine A2a receptor agonists as regulators of inflammation: pharmacology and therapeutic opportunities..J Receptor Ligand Channel Res2009;211-7

[31] Ferrari D,Antonioli L.A purinergic trail for metastases..Trends Pharmacol Sci2017;38:277-90

[32] St.Hilaire C, Carroll SH, Chen H, Ravid K. Mechanisms of induction of adenosine receptor genes and its functional significance..J Cell Physiol2009;218:35-44 PMCID:PMC3265330

[33] Allard B,Robson SC.The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets..Immunol Rev2017;276:121-44 PMCID:PMC5338647

[34] Raskovalova T,Huang X,Mandic M,Jackson EK.Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling..Cancer Res2007;67:5949-56

[35] Zarek PE,Lutz ER,Horton MR,Drake CG.A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells..Blood2008;111:251-9 PMCID:PMC2200810

[36] Lappas CM,Linden J.A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells..J Immunol2005;174:1073-80

[37] Sevigny CP,Awad AS,McDuffie M,Lobo PI.Activation of adenosine A2A receptors attenuates allograft rejection and alloantigen recognition..J Immunol2007;178:4240-9

[38] Panther E,Idzko M,Napp M,Girolomoni G.Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells..Blood2003;101:3985-90

[39] Cekic C,Sag D.Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment..Cancer Res2014;74:7250-9 PMCID:PMC4459782

[40] Morello S,Blandizzi C.Myeloid cells in the tumor microenvironment: role of adenosine..Oncoimmunology2015;5:e1108515 PMCID:PMC4839347

[41] Ohta A.Extracellular adenosine-mediated modulation of regulatory T cells..Front Immunol2014;5:304 PMCID:PMC4091046

[42] Stagg J,McLaughlin N,Pommey S,Dwyer KM.Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis..Proc Natl Acad Sci U S A2010;107:1547-52 PMCID:PMC2824381

[43] Jin D,Wang L,Liu A,Shin T,Zhang B.CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression..Cancer Res2010;70:2245-55 PMCID:PMC2883609

[44] Wang L,Thompson LF,Shin T,Zhang B.CD73 has distinct roles in non-hematopoietic and hematopoietic cells to promote tumor growth in mice..J Clin Invest2011;121:2371-82 PMCID:PMC3104756

[45] Forte G,Montinaro A,Adcock IM,Arra C,Pinto A.Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma..J Immunol2012;189:2226-33 PMCID:PMC3442235

[46] Loi S,Haibe-Kains B,Darcy PK,Stagg J.CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer..Proc Natl Acad Sci U S A2013;110:11091-6 PMCID:PMC3704029

[47] Yegutkin GG,Karikoski M,Laurila JP,Jalkanen S.Altered purinergic signaling in CD73-deficient mice inhibits tumor progression..Eur J Immunol2011;41:1231-41

[48] Quezada C,Oyarzún C,Segura R,Casanello P,San Martín R.5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells..J Cell Physiol2013;228:602-8

[49] Leclerc BG,Chouinard G,Pommey S,Stagg J.CD73 expression is an independent prognostic factor in prostate cancer..Clin Cancer Res2016;22:158-66

[50] Turcotte M,Pommey S,Cousineau I,Chen GM,Haibe-Kains B,Rahimi K,Provencher D,Stagg J.CD73 is associated with poor prognosis in high-grade serous ovarian cancer..Cancer Res2015;75:4494-503

[51] Serra S,Vaisitti T,Rossi D,D'Arena G,Tripodo C,Robson SC,Malavasi F.CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death..Blood2011;118:6141-52 PMCID:PMC3342854

[52] Wennerberg E,Demaria S.Adenosine regulates radiation therapy-induced anti-tumor immunity..J ImmunoTher Cancer2015;3:378 PMCID:PMC4649488

[53] Allard B,Smyth MJ.Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs..Clin Cancer Res2013;19:5626-35

[54] Beavis PA,Paget C,John LB,Dwyer K,Smyth MJ.Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors..Proc Natl Acad Sci U S A2013;110:14711-6 PMCID:PMC3767556

[55] Iannone R,Maiolino P,Morello S.Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model..Am J Cancer Res2014;4:172-81 PMCID:PMC3960454

[56] Mittal D,Stannard K,Teng MW,Stagg J.Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor..Cancer Res2014;74:3652-8

[57] Mittal D,Barkauskas D,Kalimutho M,Caramia F,Stagg J,Loi S.Adenosine 2B receptor expression on cancer cells promotes metastasis..Cancer Res2016;76:4372-82

[58] Bastid J,Alberici G,Eliaou JF.ENTPD1/CD39 is a promising therapeutic target in oncology..Oncogene2013;32:1743-51

[59] Fishman P,Ohana G,Ochaion A,Madi L.An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B..Oncogene2004;23:2465-71

[60] Cohen S,Zozulya G,Patoka R,Bar-Yehuda S,Jacobson KA.CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver..J Cell Physiol2011;226:2438-47 PMCID:PMC3474360

[61] Jajoo S,Watabe K.Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity..Neoplasia2009;11:1132-45 PMCID:PMC2767215

[62] Morello S,Montinaro A,Maiolino P,Arra C,Pinto A.NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model..Neoplasia2011;13:365-73 PMCID:PMC3071085

[63] Montinaro A,Sorrentino R,Palma G,Adcock IM,Morello S.Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in mice..PLoS One2012;7:e45401 PMCID:PMC3454429

[64] Silverman MH,Markovits D,Reitblat T,Rosner I,Mader R,Caspi D,Langevitz P,Friedman J,Tanay A,Cohen S,Cohn I,Farbstein M,Fishman P.Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial..J Rheumatol2008;35:41-8

[65] Fishman P,Liang BT.Pharmacological and therapeutic effects of A3 adenosine receptor agonists..Drug Discov Today2012;17:359-66 PMCID:PMC3289754

[66] Avni I,Barequet IS,Varssano D,Chetrit N,Zadok D,Litvin G,Fishman S,Farbstein M,Silverman MH,Bristol DR,Fishman P.Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial..Ophthalmology2010;117:1287-93 PMCID:PMC3668568

[67] David M,Gheorghe N,Rusinova MV,Solovastru LG,Giurcaneanu C,Purcaru AI,Tsingov II,Kadurina MI,Rotaru M,Benea V,Cosgarea MR,Michael Z,Nica C,Bristol DR,Farbstein M,Fishman P.Treatment of plaque-type psoriasis with oral CF101: data from a Phase II/III multicenter, randomized, controlled trial..J Drugs Dermatol2016;15:931-8

[68] Yang D,McCrann DJ,Kagan HM,Ravid K.The A2b adenosine receptor protects against vascular injury..Proc Natl Acad Sci U S A2008;105:792-6 PMCID:PMC2206615

[69] Sun CX,Mohsenin A,Chunn JL,Belardinelli L,Blackburn MR.Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury..J Clin Invest2006;116:2173-82 PMCID:PMC1501110

[70] Eckle T,Grenz A,Thompson LF.A2B adenosine receptor dampens hypoxia-induced vascular leak..Blood2008;111:2024-35 PMCID:PMC2739365

[71] Grenz A,Eckle T,Zhang H,Klingel K,Eltzschig HK.The reno-vascular A2B adenosine receptor protects the kidney from ischemia..PLoS Med2008;5:e137 PMCID:PMC2504049

[72] Ryzhov S,Zaynagetdinov R,Carbone DP,Dikov MM.Host A(2B) adenosine receptors promote carcinoma growth..Neoplasia2008;10:987-95 PMCID:PMC2517644

[73] Cagnina RE,Marshall MA,Frazier CR.Adenosine A2B receptors are highly expressed on murine type II alveolar epithelial cells..Am J Physiol Lung Cell Mol Physiol2009;297:L467-74 PMCID:PMC2739776

[74] Yang D,Nguyen HG,Chauhan AK,Jones MR,Seldin DC,Lamperti E,Gavras H,Ravid K.The A2B adenosine receptor protects against inflammation and excessive vascular adhesion..J Clin Invest2006;116:1913-23 PMCID:PMC1483170

[75] Casadó V,Mallol J,Lluis C.The adenosine receptors present on the plasma membrane of chromaffin cells are of the A2b subtype..J Neurochem1992;59:425-31

[76] Peakman MC.Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes..Br J Pharmacol1994;111:191-8

[77] Corset V,Forcet C,Chédotal A.Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor..Nature2000;407:747-50

[78] Nishida K,Yamanaka Y,Tsukamoto K,Ohishi A.Expression of adenosine A2b receptor in rat type II and III taste cells..Histochem Cell Biol2014;141:499-506

[79] Hua X,Chason KD,Koller BH.Enhanced mast cell activation in mice deficient in the A2b adenosine receptor..J Exp Med2007;204:117-28 PMCID:PMC2118413

[80] Novitskiy SV,Zaynagetdinov R,Huang Y,Blackburn MR,Carbone DP,Dikov MM.Adenosine receptors in regulation of dendritic cell differentiation and function..Blood2008;112:1822-31 PMCID:PMC2518889

[81] Mirabet M,Cordero OJ,Lluis C.Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation..J Cell Sci1999;112:491-502

[82] Fredholm BB,Kull B.Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells..Biochem Pharmacol2001;61:443-8in Chinese

[83] Eltzschig HK,Furuta GT,Jacobson KA,Robson SC.Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors..J Exp Med2003;198:783-96 PMCID:PMC2194189

[84] Zhao P,Yang M,Wang D,Song H,Zhang Y.Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway..Mol Immunol2008;45:2187-95

[85] Feoktistov I,Zhong H,Matafonov A,Biaggioni I.Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype..Hypertension2004;44:649-54

[86] Zhong H,Maa T.Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts..Am J Respir Cell Mol Biol2005;32:2-8

[87] Kong T,Faigle M,Colgan SP.HIF-dependent induction of adenosine A2B receptor in hypoxia..FASEB J2006;20:2242-50

[88] Xaus J,Lloberas J,Lluis C,Celada A.IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation..J Immunol1999;162:3607-14

[89] Németh ZH,Deitch EA,Szabó C.cDNA microarray analysis reveals a nuclear factor-kappaB-independent regulation of macrophage function by adenosine..J Pharmacol Exp Ther2003;306:1042-9

[90] St Hilaire C,Carroll SH,Ravid K.TNF-alpha upregulates the A2B adenosine receptor gene: the role of NAD(P)H oxidase 4..Biochem Biophys Res Commun2008;375:292-6 PMCID:PMC2583397

[91] Nguyen DK,Williams AJ,Cronstein BN.Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells..J Immunol2003;171:3991-8

[92] Schingnitz U,Macmanus CF,Zug S,Eltzschig HK.Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury..J Immunol2010;184:5271-9 PMCID:PMC2858788

[93] Kolachala VL,Obertone TS,Yan Y,Gewirtz AT,Sitaraman SV.Adenosine 2B receptor expression is post-transcriptionally regulated by microRNA..J Biol Chem2010;285:18184-90 PMCID:PMC2881742

[94] Nakatsukasa H,Harada H.Adenosine A2B receptor antagonist suppresses differentiation to regulatory T cells without suppressing activation of T cells..Biochem Biophys Res Commun2011;409:114-9

[95] Warabi M,Hirokawa K.Loss of MHC class II expression is associated with a decrease of tumor-infiltrating T cells and an increase of metastatic potential of colorectal cancer: immunohistological and histopathological analyses as compared with normal colonic mucosa and adenomas..Pathol Res Pract2000;196:807-15

[96] Shi B,Alia P,Chen F,Gelpi C,Fabra A.Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development..Int J Biochem Cell Biol2006;38:544-62

[97] Fang M,Wu X,Wang H,Xu Y.Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells..Eur J Immunol2013;43:2162-73

[98] Xia J,Wu X,Yu L,Kong H,Wang H,Xu Y.A2b adenosine signaling represses CIITA transcription via an epigenetic mechanism in vascular smooth muscle cells..Biochim Biophys Acta2015;1849:665-76

[99] Ben Addi A,Hua X,Communi D,Macours P,Boeynaems JM.Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor..Eur J Immunol2008;38:1610-20

[100] Wilson JM,Agbai ON,Figler RA,Linden J.The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells..J Immunol2009;182:4616-23 PMCID:PMC2989878

[101] Xaus J,Cardó M,Beleta J,Celada A.Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression..J Immunol1999;163:4140-9

[102] Ryzhov S,Goldstein AE,Blackburn MR,Dikov MM.Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells..J Immunol2011;187:6120-9 PMCID:PMC3221925

[103] Gabrilovich DI,Bronte V.Coordinated regulation of myeloid cells by tumours..Nat Rev Immunol2012;12:253-68 PMCID:PMC3587148

[104] Cekic C,Li Y,Strieter RM.Adenosine A2B receptor blockade slows growth of bladder and breast tumors..J Immunol2012;188:198-205 PMCID:PMC3819109

[105] Iannone R,Maiolino P,Morello S.Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma..Neoplasia2013;15:1400-9 PMCID:PMC3884531

[106] Morello S.Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells..Oncoimmunology2014;3:e27989 PMCID:PMC4121336

[107] Wei Q,Balasubramanian R,Jacobson KA.A2B adenosine receptor blockade inhibits growth of prostate cancer cells..Purinergic Signal2013;9:271-80 PMCID:PMC3646116

[108] Vecchio EA,Gregory KJ,White PJ.Ligand-independent adenosine A2B receptor constitutive activity as a promoter of prostate cancer cell proliferation..J Pharmacol Exp Ther2016;357:36-44

[109] Kasama H,Kasamatsu A,Koyama T,Ogawara K,Shiiba M,Uzawa K.Adenosine A2b receptor promotes progression of human oral cancer..BMC Cancer2015;15:563 PMCID:PMC4520274

[110] Gessi S,Varani K,Benini A,Leung E,Feo C,Borea PA.Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype..J Cell Physiol2007;211:826-36

[111] Ma DF,Nakazawa T,Mochizuki K,Yamane T.Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells..Hum Pathol2010;41:1550-7

[112] Wang P,Zong W,Liu G.MicroRNA-128b suppresses tumor growth and promotes apoptosis by targeting A2bR in gastric cancer..Biochem Biophys Res Commun2015;467:798-804

[113] Long JS,Graczyk D,Ryan KM.p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death..Oncogene2015;34:5152-62 PMCID:PMC4761646

[114] Hajiahmadi S,Aghaei M.Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3..Biochem Cell Biol2015;93:321-9

[115] Daniele S,Natali L,Trincavelli ML.Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy..Cell Death Dis2014;5:e1539 PMCID:PMC4260745

[116] Desmet CJ,Prieur A,Visser NL,Smit MA,Laoukili J,Rodenko B,Evers B,Ajouaou A,van Vliet M,Wessels LF.Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis..Proc Natl Acad Sci U S A2013;110:5139-44 PMCID:PMC3612632

[117] Przybylski M.A review of the current research on the role of bFGF and VEGF in angiogenesis..J Wound Care2009;18:516-9

[118] Feoktistov I,Ryzhov S,Belardinelli L,Biaggioni I.Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation..Circ Res2002;90:531-8

[119] Feoktistov I,Zhong H,Matafonov A,Biaggioni I.Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype..Hypertension2004;44:649-54

[120] Merighi S,Gessi S,Mirandola P,Baraldi PG.A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin..Neoplasia2009;11:1064-73 PMCID:PMC2745672

[121] Zeng D,Wang U,Biaggioni I.Expression and function of A 2B adenosine receptors in the U87MG tumor cells..Drug Develop Res2003;58:405-11

[122] Sorrentino C,Porta A,Morello S.Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model..Oncotarget2015;6:27478-89 PMCID:PMC4695003

[123] Murdoch C,Coffelt SB.The role of myeloid cells in the promotion of tumour angiogenesis..Nat Rev Cancer2008;8:618-31

[124] Allard B,Spring K,Royal I.Anti-CD73 therapy impairs tumor angiogenesis..Int J Cancer2014;134:1466-73

[125] Sorrentino C,Porta A,Morello S.Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression..Oncotarget2016;7:64274-88 PMCID:PMC5325441

[126] Orimo A,Sgroi DC,Delaunay T,Carey VJ,Weinberg RA.Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion..Cell2005;121:335-48

[127] Öhlund D,Tuveson D.Fibroblast heterogeneity in the cancer wound..J Exp Med2014;211:1503-23 PMCID:PMC4113948